Why Bionano Genomics Stock Soared on Monday

31
24
Favorite

Why Bionano Genomics Stock Soared on Monday

Motley Fool2021-06-08

The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（24）

chenlinkng85
·2021-06-14
Buy?
Reply
Like
Report
KW1
·2021-06-08
Buy bngo now
Reply
Like
Report
HappyTrade
·2021-06-08
Hope it will continue in this way... Up up & away to the moon[財迷]
Reply
Like
Report
nimrod
·2021-06-08
It's a great technology for humans
Reply
Like
Report
好話上
·2021-06-08
To the moon please. I believe in Saphyr and it's even better if it become a meme stock!
Reply
Like
Report
Fold Replies
- nimrod:
  It can cure diseases before they even happen
  2021-06-08
  Reply
  Report
Juelo
·2021-06-08
Feasible
Reply
Like
Report
ahbenAR
·2021-06-08
Like & comments please.
Reply
2
Report
Fold Replies
- EsmeT:
  ?? Like Reply back too pls!
  2021-06-08
  Reply
  Report
- XIN90:
  Here
  2021-06-08
  Reply
  Report
yyhwin12345
·2021-06-08
Like and comment please
Reply
2
Report
Fold Replies
- XIN90:
  Here
  2021-06-08
  Reply
  Report
- yyhwin:
  Comment
  2021-06-08
  Reply
  Report
- yyhwin12345:
  Please like and comment
  2021-06-08
  Reply
  Report
View more 1 comments
ParableTalen
·2021-06-08
Bingo
Reply
2
Report
AloysiusTeh
·2021-06-08
Like pls
Reply
1
Report
Fold Replies
- thuiminn:
  like and comment
  2021-06-08
  Reply
  Report
- Zu_K70:
  Done and reply pls
  2021-06-08
  Reply
  Report
Yuanecute
·2021-06-08
like and comment pls
Reply
2
Report
Fold Replies
- Zu_K70:
  OK and reply
  2021-06-08
  Reply
  Report
Anonymous2
·2021-06-08
Like and comment please
Reply
5
Report
Fold Replies
- nimrod:
  Cheers
  2021-06-08
  Reply
  Report
- Zu_K70:
  Ok and reply
  2021-06-08
  Reply
  Report
chowchoww
·2021-06-08
Like pls
Reply
3
Report
Fold Replies
- Anonymous2:
  Pls reply to my comment
  2021-06-08
  Reply
  Report
RuyiOng
·2021-06-08
Pls comment
Reply
3
Report
Fold Replies
- LeeWan:
  Ok
  2021-06-08
  Reply
  Report
PapiChulo88
·2021-06-08
Hopefully it will sustain in the Long run
Reply
2
Report
missychatty
·2021-06-08
Yesss!!
Reply
4
Report
Fold Replies
- Gankl:
  YeSs
  2021-06-09
  Reply
  Report
Jon89
·2021-06-08
Comment and like pls
Reply
3
Report
Fold Replies
- missychatty:
  Like and comment back
  2021-06-08
  Reply
  Report
- Judgers:
  Ok. pls do the same too
  2021-06-08
  Reply
  Report
- RuyiOng:
  pls comment
  2021-06-08
  Reply
  Report
View more 1 comments
nakazatous
·2021-06-08
Like my comment
Reply
5
Report
Fold Replies
- Jon89:
  Reply pls
  2021-06-08
  Reply
  Report
- nakazatous:
  Ok
  2021-06-08
  Reply
  Report
Carolir
·2021-06-08
.
Reply
5
Report
mcccccc6
·2021-06-08
2nsn2
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1151090475?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-08 16:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151090475","market":"us","top_or_hot":-1,"title":"Why Bionano Genomics Stock Soared on Monday","media":"Motley Fool","content":"<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Source Link</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNGO","symbol_name":"Bionano Genomics","start_time":0,"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","article_id":"1151090475","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","pubTimestamp":1623140703,"sourceInfo":null,"weMediaInfo":null,"summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNGO":"Bionano Genomics"},"translate_title":"Bionano Genomics股价周一大涨的原因","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNGO":0.9},"content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":185669769,"gmtCreate":1623646502451,"gmtModify":1704207760041,"author":{"id":"3576964557898676","authorId":"3576964557898676","name":"chenlinkng85","avatar":"https://community-static.tradeup.com/news/96af4b47156ad9327a31f9894b8ca358","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3576964557898676","idStr":"3576964557898676"},"htmlText":"Buy?","listText":"Buy?","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/185669769","repostId":1151090475,"repostType":2,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117716979,"gmtCreate":1623160539691,"gmtModify":1704197371877,"author":{"id":"3563714281601583","authorId":"3563714281601583","name":"KW1","avatar":"https://static.tigerbbs.com/094e3f8fd8b3de3da976515926ed1403","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":7,"crmLevelSwitch":1,"authorIdStr":"3563714281601583","idStr":"3563714281601583"},"htmlText":"Buy bngo now","listText":"Buy bngo now","text":"Buy bngo now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117716979","repostId":1151090475,"repostType":2,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117799949,"gmtCreate":1623159926881,"gmtModify":1704197338026,"author":{"id":"3561676944889444","authorId":"3561676944889444","name":"HappyTrade","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3561676944889444","idStr":"3561676944889444"},"htmlText":"Hope it will continue in this way... Up up &amp; away to the moon[財迷]&nbsp;","listText":"Hope it will continue in this way... Up up &amp; away to the moon[財迷]&nbsp;","text":"Hope it will continue in this way... Up up & away to the moon[財迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117799949","repostId":1151090475,"repostType":2,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":117485629,"gmtCreate":1623157547961,"gmtModify":1704197253175,"author":{"id":"3565239129539076","authorId":"3565239129539076","name":"nimrod","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3565239129539076","idStr":"3565239129539076"},"htmlText":"It's a great technology for humans","listText":"It's a great technology for humans","text":"It's a great technology for humans","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117485629","repostId":1151090475,"repostType":2,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117579200,"gmtCreate":1623154399800,"gmtModify":1704197174664,"author":{"id":"3557184148845388","authorId":"3557184148845388","name":"好話上","avatar":"https://static.tigerbbs.com/691862de47dca4069347160f30fd6f29","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3557184148845388","idStr":"3557184148845388"},"htmlText":"To the moon please. I believe in Saphyr and it's even better if it become a meme stock!","listText":"To the moon please. I believe in Saphyr and it's even better if it become a meme stock!","text":"To the moon please. I believe in Saphyr and it's even better if it become a meme stock!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117579200","repostId":1151090475,"repostType":2,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4633882,"gmtCreate":1623157581424,"gmtModify":1663228207250,"authorId":3565239129539076,"author":{"id":3565239129539076,"idStr":"3565239129539076","authorId":3565239129539076,"name":"nimrod","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117579200,"type":1,"supId":0,"prevId":0,"content":"It can cure diseases before they even <u>happen</u>","text":"It can cure diseases before they even <u>happen</u>","html":"It can cure diseases before they even <u>happen</u>"}],"langContent":"EN"},{"id":117596649,"gmtCreate":1623148892681,"gmtModify":1704197068911,"author":{"id":"3584151097809421","authorId":"3584151097809421","name":"Juelo","avatar":"https://static.tigerbbs.com/44b1b2a7ad3407d486dd49dd047d2b80","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":7,"crmLevelSwitch":1,"authorIdStr":"3584151097809421","idStr":"3584151097809421"},"htmlText":"Feasible&nbsp;","listText":"Feasible&nbsp;","text":"Feasible","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117596649","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117237141,"gmtCreate":1623142620583,"gmtModify":1704196949155,"author":{"id":"3585564727665393","authorId":"3585564727665393","name":"ahbenAR","avatar":"https://static.tigerbbs.com/b7bd20105f5f31583b7a0b4fd62a5993","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585564727665393","idStr":"3585564727665393"},"htmlText":"Like &amp; comments please.&nbsp;","listText":"Like &amp; comments please.&nbsp;","text":"Like & comments please.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/117237141","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4632459,"gmtCreate":1623149213865,"gmtModify":1663228199743,"authorId":3583324925442360,"author":{"id":3583324925442360,"idStr":"3583324925442360","authorId":3583324925442360,"name":"EsmeT","avatar":"https://static.tigerbbs.com/2de5124e6af354a5501487b248f6a83b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117237141,"type":1,"supId":4631938,"prevId":0,"content":"?? Like Reply back too pls!","text":"?? Like Reply back too pls!","html":"?? Like Reply back too pls!"},{"id":4631938,"gmtCreate":1623146112369,"gmtModify":1663228198027,"authorId":3575421183576572,"author":{"id":3575421183576572,"idStr":"3575421183576572","authorId":3575421183576572,"name":"XIN90","avatar":"https://static.tigerbbs.com/a03ad25cd0afaee9bf2e99b32ad14452","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117237141,"type":1,"supId":0,"prevId":0,"content":"Here","text":"Here","html":"Here"}],"langContent":"EN"},{"id":117235266,"gmtCreate":1623142494355,"gmtModify":1704196947044,"author":{"id":"3586228965364851","authorId":"3586228965364851","name":"yyhwin12345","avatar":"https://static.tigerbbs.com/f73f48f7dbf02904c9a179fb59cc138d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586228965364851","idStr":"3586228965364851"},"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/117235266","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4631949,"gmtCreate":1623146160146,"gmtModify":1663228197746,"authorId":3575421183576572,"author":{"id":3575421183576572,"idStr":"3575421183576572","authorId":3575421183576572,"name":"XIN90","avatar":"https://static.tigerbbs.com/a03ad25cd0afaee9bf2e99b32ad14452","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117235266,"type":1,"supId":0,"prevId":0,"content":"Here","text":"Here","html":"Here"},{"id":4631966,"gmtCreate":1623146281620,"gmtModify":1663228197540,"authorId":3581931076615563,"author":{"id":3581931076615563,"idStr":"3581931076615563","authorId":3581931076615563,"name":"yyhwin","avatar":"https://static.tigerbbs.com/78727032603c2751ac0b6b6cfb678920","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117235266,"type":1,"supId":0,"prevId":0,"content":"Comment","text":"Comment","html":"Comment"},{"id":4631911,"gmtCreate":1623145899652,"gmtModify":1663228197446,"authorId":3586228965364851,"author":{"id":3586228965364851,"idStr":"3586228965364851","authorId":3586228965364851,"name":"yyhwin12345","avatar":"https://static.tigerbbs.com/f73f48f7dbf02904c9a179fb59cc138d","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.05","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117235266,"type":1,"supId":0,"prevId":0,"content":"Please like and comment","text":"Please like and comment","html":"Please like and comment"},{"id":4632049,"gmtCreate":1623146679327,"gmtModify":1663228197444,"authorId":3581931076615563,"author":{"id":3581931076615563,"idStr":"3581931076615563","authorId":3581931076615563,"name":"yyhwin","avatar":"https://static.tigerbbs.com/78727032603c2751ac0b6b6cfb678920","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117235266,"type":1,"supId":4631911,"prevId":0,"content":"Replied","text":"Replied","html":"Replied"}],"langContent":"EN"},{"id":117239518,"gmtCreate":1623142198834,"gmtModify":1704196938360,"author":{"id":"3580300192386766","authorId":"3580300192386766","name":"ParableTalen","avatar":"https://static.tigerbbs.com/94daa928259bc550d0ee26f23a953bb8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3580300192386766","idStr":"3580300192386766"},"htmlText":"Bingo","listText":"Bingo","text":"Bingo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117239518","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117294599,"gmtCreate":1623142032611,"gmtModify":1704196934603,"author":{"id":"3570890333574915","authorId":"3570890333574915","name":"AloysiusTeh","avatar":"https://static.tigerbbs.com/b3ab529277f15a771f15f99c794a1243","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3570890333574915","idStr":"3570890333574915"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/117294599","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4631257,"gmtCreate":1623142320543,"gmtModify":1663228190332,"authorId":3582403330807441,"author":{"id":3582403330807441,"idStr":"3582403330807441","authorId":3582403330807441,"name":"thuiminn","avatar":"https://static.tigerbbs.com/ab77e304f9cf03ebe236699fa09e54b7","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117294599,"type":1,"supId":0,"prevId":0,"content":"like and <u>comment</u>","text":"like and <u>comment</u>","html":"like and <u>comment</u>"},{"id":4631266,"gmtCreate":1623142367405,"gmtModify":1635332307223,"authorId":3581911520647961,"author":{"id":3581911520647961,"idStr":"3581911520647961","authorId":3581911520647961,"name":"Zu_K70","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.18","exceedPercentage":"93.48%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":8,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117294599,"type":1,"supId":4631257,"prevId":0,"content":"Done and reply pls","text":"Done and reply pls","html":"Done and reply pls"}],"langContent":"EN"},{"id":117292027,"gmtCreate":1623141929769,"gmtModify":1704196930692,"author":{"id":"3583210195403389","authorId":"3583210195403389","name":"Yuanecute","avatar":"https://static.tigerbbs.com/b16771be0bfff1b89dc4e942803ce2c2","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3583210195403389","idStr":"3583210195403389"},"htmlText":"like and comment pls&nbsp;","listText":"like and comment pls&nbsp;","text":"like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117292027","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4631269,"gmtCreate":1623142384153,"gmtModify":1663228191739,"authorId":3581911520647961,"author":{"id":3581911520647961,"idStr":"3581911520647961","authorId":3581911520647961,"name":"Zu_K70","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.18","exceedPercentage":"93.48%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":8,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117292027,"type":1,"supId":0,"prevId":0,"content":"OK and reply","text":"OK and reply","html":"OK and reply"}],"langContent":"EN"},{"id":117202567,"gmtCreate":1623141336359,"gmtModify":1704196917384,"author":{"id":"3560247957239615","authorId":"3560247957239615","name":"Anonymous2","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3560247957239615","idStr":"3560247957239615"},"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/117202567","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4633879,"gmtCreate":1623157558006,"gmtModify":1663228208634,"authorId":3565239129539076,"author":{"id":3565239129539076,"idStr":"3565239129539076","authorId":3565239129539076,"name":"nimrod","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117202567,"type":1,"supId":4631271,"prevId":0,"content":"Cheers","text":"Cheers","html":"Cheers"},{"id":4631271,"gmtCreate":1623142390856,"gmtModify":1663228192735,"authorId":3581911520647961,"author":{"id":3581911520647961,"idStr":"3581911520647961","authorId":3581911520647961,"name":"Zu_K70","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.18","exceedPercentage":"93.48%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":8,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117202567,"type":1,"supId":0,"prevId":0,"content":"Ok and reply","text":"Ok and reply","html":"Ok and reply"}],"langContent":"EN"},{"id":117201559,"gmtCreate":1623141243371,"gmtModify":1704196913969,"author":{"id":"3574909344077682","authorId":"3574909344077682","name":"chowchoww","avatar":"https://static.tigerbbs.com/273e81063110370ec027e4541d9ce720","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3574909344077682","idStr":"3574909344077682"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117201559","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4631032,"gmtCreate":1623141349086,"gmtModify":1663228191546,"authorId":3560247957239615,"author":{"id":3560247957239615,"idStr":"3560247957239615","authorId":3560247957239615,"name":"Anonymous2","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117201559,"type":1,"supId":0,"prevId":0,"content":"Pls reply to my comment","text":"Pls reply to my comment","html":"Pls reply to my comment"}],"langContent":"EN"},{"id":117203784,"gmtCreate":1623141225148,"gmtModify":1704196911868,"author":{"id":"3581843901915824","authorId":"3581843901915824","name":"RuyiOng","avatar":"https://static.tigerbbs.com/0f0f607e2db1a857ce6e533079ad3d78","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581843901915824","idStr":"3581843901915824"},"htmlText":"Pls comment","listText":"Pls comment","text":"Pls comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117203784","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4631025,"gmtCreate":1623141333719,"gmtModify":1663228191549,"authorId":3558097748623340,"author":{"id":3558097748623340,"idStr":"3558097748623340","authorId":3558097748623340,"name":"LeeWan","avatar":"https://static.tigerbbs.com/88769849d29a340fce73355c249755a4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117203784,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":117209462,"gmtCreate":1623141170956,"gmtModify":1704196910077,"author":{"id":"3576458191145383","authorId":"3576458191145383","name":"PapiChulo88","avatar":"https://static.tigerbbs.com/c96f770d89e4ec52569d75c168c27695","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576458191145383","idStr":"3576458191145383"},"htmlText":"Hopefully it will sustain in the Long run","listText":"Hopefully it will sustain in the Long run","text":"Hopefully it will sustain in the Long run","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117209462","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117209927,"gmtCreate":1623141117269,"gmtModify":1704196908943,"author":{"id":"3560333139103013","authorId":"3560333139103013","name":"missychatty","avatar":"https://static.tigerbbs.com/d75cdb42cbca99e3666b7b1796540245","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3560333139103013","idStr":"3560333139103013"},"htmlText":"Yesss!!","listText":"Yesss!!","text":"Yesss!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117209927","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4641713,"gmtCreate":1623200419602,"gmtModify":1663228243926,"authorId":3567000750441814,"author":{"id":3567000750441814,"idStr":"3567000750441814","authorId":3567000750441814,"name":"Gankl","avatar":"https://static.tigerbbs.com/130aaa22ea9d4a3626b320dcd8401ea3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117209927,"type":1,"supId":0,"prevId":0,"content":"YeSs","text":"YeSs","html":"YeSs"}],"langContent":"EN"},{"id":117200853,"gmtCreate":1623141093572,"gmtModify":1704196907809,"author":{"id":"3581678918909639","authorId":"3581678918909639","name":"Jon89","avatar":"https://static.tigerbbs.com/30b3d43718a133f47da22154d533f71e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581678918909639","idStr":"3581678918909639"},"htmlText":"Comment and like pls&nbsp;","listText":"Comment and like pls&nbsp;","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/117200853","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4630957,"gmtCreate":1623141129714,"gmtModify":1663228192627,"authorId":3560333139103013,"author":{"id":3560333139103013,"idStr":"3560333139103013","authorId":3560333139103013,"name":"missychatty","avatar":"https://static.tigerbbs.com/d75cdb42cbca99e3666b7b1796540245","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117200853,"type":1,"supId":0,"prevId":0,"content":"Like and comment back","text":"Like and comment back","html":"Like and comment back"},{"id":4630984,"gmtCreate":1623141234914,"gmtModify":1663228191642,"authorId":3566321437917881,"author":{"id":3566321437917881,"idStr":"3566321437917881","authorId":3566321437917881,"name":"Judgers","avatar":"https://static.tigerbbs.com/a761a14762018f4253888680f7fe7965","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117200853,"type":1,"supId":4630957,"prevId":0,"content":"Ok. pls do the same too","text":"Ok. pls do the same too","html":"Ok. pls do the same too"},{"id":4630988,"gmtCreate":1623141243300,"gmtModify":1663228191459,"authorId":3581843901915824,"author":{"id":3581843901915824,"idStr":"3581843901915824","authorId":3581843901915824,"name":"RuyiOng","avatar":"https://static.tigerbbs.com/0f0f607e2db1a857ce6e533079ad3d78","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117200853,"type":1,"supId":4630957,"prevId":0,"content":"pls <u>comment</u>","text":"pls <u>comment</u>","html":"pls <u>comment</u>"},{"id":4630995,"gmtCreate":1623141266872,"gmtModify":1663228191455,"authorId":3560333139103013,"author":{"id":3560333139103013,"idStr":"3560333139103013","authorId":3560333139103013,"name":"missychatty","avatar":"https://static.tigerbbs.com/d75cdb42cbca99e3666b7b1796540245","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117200853,"type":1,"supId":4630957,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":117677682,"gmtCreate":1623141054746,"gmtModify":1704196906677,"author":{"id":"3570519374633708","authorId":"3570519374633708","name":"nakazatous","avatar":"https://static.tigerbbs.com/9ac34656b654252df0f82999785e92ae","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3570519374633708","idStr":"3570519374633708"},"htmlText":"Like my comment","listText":"Like my comment","text":"Like my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/117677682","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4630951,"gmtCreate":1623141109317,"gmtModify":1663228191749,"authorId":3581678918909639,"author":{"id":3581678918909639,"idStr":"3581678918909639","authorId":3581678918909639,"name":"Jon89","avatar":"https://static.tigerbbs.com/30b3d43718a133f47da22154d533f71e","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.28%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117677682,"type":1,"supId":0,"prevId":0,"content":"Reply pls","text":"Reply pls","html":"Reply pls"},{"id":4630954,"gmtCreate":1623141125671,"gmtModify":1663228191731,"authorId":3570519374633708,"author":{"id":3570519374633708,"idStr":"3570519374633708","authorId":3570519374633708,"name":"nakazatous","avatar":"https://static.tigerbbs.com/9ac34656b654252df0f82999785e92ae","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117677682,"type":1,"supId":4630951,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":117677875,"gmtCreate":1623141053097,"gmtModify":1704196907162,"author":{"id":"3576326025007657","authorId":"3576326025007657","name":"Carolir","avatar":"https://static.tigerbbs.com/7336f44d3eff2834f40e92f17d72ed7e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3576326025007657","idStr":"3576326025007657"},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117677875","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117677339,"gmtCreate":1623141046821,"gmtModify":1704196906191,"author":{"id":"3557115305021464","authorId":"3557115305021464","name":"mcccccc6","avatar":"https://static.tigerbbs.com/afa6344d47cc0c544ff888306c0941b3","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3557115305021464","idStr":"3557115305021464"},"htmlText":"2nsn2","listText":"2nsn2","text":"2nsn2","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117677339","repostId":1151090475,"repostType":4,"repost":{"id":"1151090475","pubTimestamp":1623140703,"share":"https://ttm.financial/m/news/1151090475?lang=&edition=fundamental","pubTime":"2021-06-08 16:25","market":"us","language":"en","title":"Why Bionano Genomics Stock Soared on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151090475","media":"Motley Fool","summary":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Gen","content":"<blockquote><b>The genetic testing specialist is bolstering its leadership ranks.</b></blockquote><p><b>What happened</b></p><p>Shares of&nbsp;<b>Bionano Genomics</b>&nbsp;(NASDAQ:BNGO)&nbsp;surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.</p><p><b>So what</b></p><p>Jason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.</p><p>Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.</p><p>\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"</p><p><b>Now what</b></p><p>Mentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.</p><p>Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bionano Genomics Stock Soared on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bionano Genomics Stock Soared on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.fool.com/investing/2021/06/07/why-bionano-genomics-stock-soared-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151090475","content_text":"The genetic testing specialist is bolstering its leadership ranks.What happenedShares of Bionano Genomics (NASDAQ:BNGO) surged 22% on Monday after the genome analysis company announced the hiring of a new chief commercial officer.So whatJason Priar will head up Bionano's sales teams and spearhead its revenue growth initiatives. He will be charged with striking deals with insurance companies and other third-party payers.Priar previously served in healthcare-related sales and leadership positions at businesses including Forest Laboratories, PerkinElmer Genomics, and genetic testing specialist GeneDx. Notably, Priar helped GeneDx's sales rise from $8 million to more than $225 million during his time at the company.\"Jason's intimate familiarity with the needs of traditional cytogenomics laboratories performing genome analysis in cancer and genetic diseases, combined with his understanding of needs of the physicians and pharmaceutical partners who apply the data, is among the best I have encountered in the industry,\" Bionano CEO Erik Holmlin said in a press release. \"I believe adding Jason to an already stellar team can have a profound impact on Bionano.\"Now whatMentions regarding Bionano have ramped up on Reddit's investing forums in recent days. Some traders appear to be attempting to create ashort squeezein the biotech's shares. This sharp increase in bullish chatter on social media sites likely also contributed to Bionano's gains on Monday.Yet Bionano is more than just a meme stock. Its Saphyr genome mapping system is earning strong reviews from healthcare researchers. Analysts, in turn, see plenty of upside for its shares. The consensus estimate calls for Bionano's stock to reach $12 in the next year -- or about 43% above its closing price on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":31,"commentSize":24,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}